
Nivolumab - Wikipedia
Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication in the class of immune checkpoint inhibitors. It selectively binds and blocks the programmed death-1 (PD-1) receptor on T …
Nivolumab: Uses, Dosage, Side Effects & Warnings - Drugs.com
Jun 15, 2025 · Nivolumab may be used alone or in combination with other medicines, such as ipilimumab (Yervoy) or chemotherapy. Nivolumab is an immune checkpoint inhibitor that works by …
Nivolumab - NCI - National Cancer Institute
Nivolumab works by binding to and blocking the protein PD-1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This allows the immune system to attack …
Nivolumab (intravenous route) - Side effects & uses - Mayo Clinic
Nov 1, 2025 · Nivolumab injection is used alone or together with other medicines (eg, ipilimumab) to treat melanoma (skin cancer) that has spread throughout the body (metastatic) or that cannot be …
Nivolumab - StatPearls - NCBI Bookshelf
Feb 28, 2024 · Nivolumab is a monoclonal antibody for managing metastatic melanoma and other malignancies. The drug targets the PD1 receptor, an immune checkpoint, thus embodying a potent …
Nivolumab: Cancer Treatment Uses, Side Effects, Warnings
Nivolumab is a type of targeted therapy that does not directly kill cancer cells, but targets and alters a specific cell mechanism that promotes cancer growth and spread. Nivolumab works by stimulating …
Nivolumab Injection: MedlinePlus Drug Information
Why is this medication prescribed? Nivolumab injection is used to treat a variety of cancers. Nivolumab is in a class of medications called monoclonal antibodies. It works by helping your immune system to …
Nivolumab - Memorial Sloan Kettering Cancer Center
Dec 12, 2022 · Nivolumab Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when …
Nivolumab (Opdivo®) - OncoLink
Feb 19, 2024 · Nivolumab works as a form of immunotherapy by binding to the "programmed death receptor" (PD1) found on T-cells to stimulate the immune system to find and kill cancer cells.
Nivolumab (Opdivo) - Cancer Research UK
Nivolumab is a type of cancer treatment called an immunotherapy. It is a treatment for a number of different types of cancer. Find out about how you have it, possible side effects, and other important …